Skip to main content

Table 2 Ezrin overexpression and clinicopathological features of cervical cancers

From: High expression of ezrin predicts poor prognosis in uterine cervical cancer

Clinical features Cases (n) Strongly positive cases n. (%) P-value
Histological types 226   
  Keratinizing 125 96 (76.8%) NS
  Non-keratinizing 101 71 (70.3%)  
Differentiation 235   
  Poorly diff. 35 33 (94.3%)* <0.05a
  Moderately diff. 106 89 (84.0%)*  
  Well diff. 94 53 (56.4%)  
Staging 235   
 Early (I-IIA) 108 53 (49.1%) <0.05b
  IA 16 5 (31.3%)  
  IB 41 22 (53.7%)  
  IIA 51 26 (51.0%)  
 Late (IIB-IV) 127 122 (96.1%)**  
  IIB 11 9 (81.8%)  
  IIIA 12 11 (91.7%)  
  IIIB 46 44 (95.7%)  
  IVA 41 41 (100%)  
  IVB 17 17 (100%)  
LN Metastasis 235   
  Positive   104 104 (100%)* <0.05
  Negative   131 71 (54.2%)  
  1. Diff.: differentiation; NS: not significant *P<0.05 **P<0.01.
  2. a Poorly & moderately diff. vs well diff. b early stage (stage-IA + stage-IB + stage-IIA) vs late stage (stage-IIB + stage-III + stage-IV).